Predictive value of preoperative volume-based 18F-2-Fluoro-2-Deoxy-D-Glucose position emission tomography/computed tomography parameters in patients with resectable lung adenocarcinoma

This study aimed to investigate the prognostic value of metabolic tumor volume (MTV) and total lesion glycolysis (TLG), which are volume-based PET parameters, using 18F-2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in patients with surgically resectable lung adenocarcinoma. We retrospectively evaluated 149 patients with lung adenocarcinoma who underwent 18F-FDG PET/CT before surgical resection. Maximum standardized uptake value (SUV_max), MTV, and TLG of the primary tumor with threshold value of SUV_max 30, 40, and 50% were calculated, respectively. To compare the predictive performance of volume-based PET parameters, recurrence-free survival was assessed using the Kaplan-Meier method. The study included 70 males and 79 females with an average age of 65.8 years. The median follow-up time was 45.4 months. Recurrence was observed in 53 patients (35.6%). The mean ± SD SUV_max, MTV_30%, and TLG_30% of the entire cohort were 4.79 ± 2.94, 19.45 ± 24.85, and 56.43 ± 101.88, respectively. The cut-off values of MTV_30% and TLG_30% for recurrence were 11.07 ad 30.56, respectively. The 1-year recurrence-free survival (RFS) rate was 96.5% in low-MTV_30% patients compared with 86.2% in high-MTV_30% patients (p = 0.018) and 96.0% in low-TLG_30% patients compared with 88.5% in high-TLG_30% patients (p < 0.001). On univariate and multivariate analysis, TLG_30% (HR, 2.828, p < 0.001; HR, 2.738, p < 0.001, respectively) was an independent prognostic factor for predicting recurrence-free survival (RFS). TLG_30% value was observed to be a significant prognostic factor for RFS in patients with lung adenocarcinoma treated by surgical resection